PELOAcademy|Compatibility of hiPSC-derived cardiomyocytes in cardiac safety assessment of drugsafety (Webinar | Online)
presented by Dr. Jieun An, Nexel Co., Ltd., Republic of Korea Cardiac toxicity is a major cause of compound attrition during drug development as well… Weiterlesen »PELOAcademy|Compatibility of hiPSC-derived cardiomyocytes in cardiac safety assessment of drugsafety (Webinar | Online)